
BANK OF IRELAND MISSING ITS OWN TARGETS
BANK OF IRELAND MISSING ITS OWN TARGETS
I-RES REIT NEEDS TO ACT ON BIG CANADIAN FEES
DEPRESSED DALATA FACES DOUBLE WHAMMY
URGENT ACTION REQUIRED AT UDG
MENEZES FAILS TO JUSTIFY £12M DIAGEO PACKAGE
OPEN ORPHAN’S STOCK MARKET PRESCRIPTION
QUESTION MARK OVER C&C AFTER GLANCEY’S EXIT
IAN IRELAND IMPRESSES AT DONEGAL INVESTMENTS
KOLLECT TAPS SCANDINAVIAN MARKET
GREENCORE’S SHARE-PRICE RISE DEFIES LOGIC
MARKET OVERDOES TULLOW SHARE COLLAPSE
FIONA MULDOON LEAVES FBD STRUGGLING
UNLOVED ORIGIN ENTERPRISES SHARES UNDER-RATED
RYANAIR’S BOTTOM LINE BOOSTED BY BOEING’S BAD NEWS
GLANBIA’S ACQUISITION STRATEGY FAILS TO DELIVER
DERMOT DESMOND AND THE DATALEX DISASTER
GREEN REIT BONANZA FAR FROM A DONE DEAL
BOOMING CPL CAN’T RECRUIT BIG SHAREHOLDERS
ARYZTA’S SLOW RECOVERY REFLECTED IN SHARE PRICE
PETRONEFT SHAREHOLDERS SHOULD PREPARE FOR THE WORST
ABBEY’S IRISH PERFORMANCE LOOKS EMBARRASSING
TONY O’REILLY JNR’S PROVIDENCE PANTOMIME
OVOCA BIO WORTH DOUBLE ITS CURRENT SHARE PRICE
UNBALANCED DALATA HOTELS’ BEDROOM PROBLEM
AIB IS UNDERVALUED BY MARKET
DCC’S HIGH SHARE RATING HARD TO JUSTIFY
WHY IS MICK O’LEARY STILL IN THE COCKPIT?
FIRST DERIVATIVES AFTER BRIAN CONLON
Jeremy Masding can’t stop the rot at Permanent TSB
Question marks over Uniphar’s prescription for success
TIME FOR WESTONS TO SPIN OUT PENNEYS/PRIMARK
FRANCESCA MCDONAGH’S PROBLEMS AT BANK OF IRELAND
JOHN FARRELL’S SUPER MISS BLUES
MALIN SHARES NOW AT 50% DISCOUNT TO ASSET VALUE
BIG BOYS IN THE ATLANTIC COULD BOOST PETREL SHARES
NAMA’S 10 TERRIBLE YEARS